# FDA Inspection 1221018 - SCA Pharmaceuticals, LLC - October 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/sca-pharmaceuticals-llc/8ed46b4e-f317-4436-8ba7-6ec1a985a96b
Source feed: FDA_Inspections

> FDA Inspection 1221018 for SCA Pharmaceuticals, LLC on October 20, 2023. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221018
- Company Name: SCA Pharmaceuticals, LLC
- Inspection Date: 2023-10-20
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1307176 - 2026-03-13](https://www.keypedia.com/records/fda_inspections/sca-pharmaceuticals-llc/773b2600-60d4-4309-a9a0-a301b9a67212)
- [FDA Inspection 1252093 - 2024-12-20](https://www.keypedia.com/records/fda_inspections/sca-pharmaceuticals-llc/5b183fe0-2abd-41cf-9bcd-aa227ebda39a)

Company: https://www.keypedia.com/companies/sca-pharmaceuticals-llc/96e2ad34-fa1e-4fb7-a281-1aeff351cecc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c